Elexacaftor/Tezacaftor/Ivacaftor Improves Glycemic Control in Pediatric Patients with Cystic Fibrosis-Related Diabetes
Publication
, Conference
Shi, M; Elmallah, M; Benjamin, R
Published in: HORMONE RESEARCH IN PAEDIATRICS
2021
Duke Scholars
Published In
HORMONE RESEARCH IN PAEDIATRICS
EISSN
1663-2826
ISSN
1663-2818
Publication Date
2021
Volume
94
Issue
SUPPL 2
Start / End Page
26 / 26
Related Subject Headings
- Endocrinology & Metabolism
- 3215 Reproductive medicine
- 3213 Paediatrics
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Shi, M., Elmallah, M., & Benjamin, R. (2021). Elexacaftor/Tezacaftor/Ivacaftor Improves Glycemic Control in Pediatric Patients with Cystic Fibrosis-Related Diabetes. In HORMONE RESEARCH IN PAEDIATRICS (Vol. 94, pp. 26–26).
Shi, Melody, Mai Elmallah, and Robert Benjamin. “Elexacaftor/Tezacaftor/Ivacaftor Improves Glycemic Control in Pediatric Patients with Cystic Fibrosis-Related Diabetes.” In HORMONE RESEARCH IN PAEDIATRICS, 94:26–26, 2021.
Shi M, Elmallah M, Benjamin R. Elexacaftor/Tezacaftor/Ivacaftor Improves Glycemic Control in Pediatric Patients with Cystic Fibrosis-Related Diabetes. In: HORMONE RESEARCH IN PAEDIATRICS. 2021. p. 26–26.
Shi, Melody, et al. “Elexacaftor/Tezacaftor/Ivacaftor Improves Glycemic Control in Pediatric Patients with Cystic Fibrosis-Related Diabetes.” HORMONE RESEARCH IN PAEDIATRICS, vol. 94, no. SUPPL 2, 2021, pp. 26–26.
Shi M, Elmallah M, Benjamin R. Elexacaftor/Tezacaftor/Ivacaftor Improves Glycemic Control in Pediatric Patients with Cystic Fibrosis-Related Diabetes. HORMONE RESEARCH IN PAEDIATRICS. 2021. p. 26–26.
Published In
HORMONE RESEARCH IN PAEDIATRICS
EISSN
1663-2826
ISSN
1663-2818
Publication Date
2021
Volume
94
Issue
SUPPL 2
Start / End Page
26 / 26
Related Subject Headings
- Endocrinology & Metabolism
- 3215 Reproductive medicine
- 3213 Paediatrics
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences